Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2022
Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
Seung Yeon Oh, You Won Lee, Eun Ji Lee, et al.
Cell Reports. Medicine
|
January 28, 2025
The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC
Seung Yeon Oh, Sewon Park, Seoyoung Lee, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines
Sung-Moo Kim, Hwan Kim, Kang Won Jang, et al.
Scientific Reports
|
December 29, 2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma
Seok-Young Kim, Sang-Min Kim, Sumin Lim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 13, 2016
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer
Kyoung Ho Pyo, Sun Min Lim, Hye Ryun Kim, et al.
Experimental & Molecular Medicine
|
August 23, 2022
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy
Haejeong Heo, Jong-Hwan Kim, Hyun Jung Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 8, 2024
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC
Eun Ji Lee, Seung Yeon Oh, You Won Lee, et al.
Molecular Cancer Therapeutics
|
July 26, 2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
Chan Woo Kang, Kang Won Jang, Jinyoung Sohn, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 5, 2016
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
Han Na Kang, Se-Ho Kim, Mi Ran Yun, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2022
Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
Seung Yeon Oh, You Won Lee, Eun Ji Lee, et al.
Cell Reports. Medicine
|
January 28, 2025
The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC
Seung Yeon Oh, Sewon Park, Seoyoung Lee, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines
Sung-Moo Kim, Hwan Kim, Kang Won Jang, et al.
Scientific Reports
|
December 29, 2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma
Seok-Young Kim, Sang-Min Kim, Sumin Lim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 13, 2016
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer
Kyoung Ho Pyo, Sun Min Lim, Hye Ryun Kim, et al.
Experimental & Molecular Medicine
|
August 23, 2022
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy
Haejeong Heo, Jong-Hwan Kim, Hyun Jung Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 8, 2024
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC
Eun Ji Lee, Seung Yeon Oh, You Won Lee, et al.
Molecular Cancer Therapeutics
|
July 26, 2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
Chan Woo Kang, Kang Won Jang, Jinyoung Sohn, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 5, 2016
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
Han Na Kang, Se-Ho Kim, Mi Ran Yun, et al.
Page
of 7